Trump’s bold new plan aims to revamp America’s drug supply by slashing tariffs on generics for two years—then hitting them with 100% and later 200% duties—to force U.S. manufacturing. Framed as a national security move, it targets foreign reliance and follows earlier brand-name drug tariffs. Pharma giants are calling for clarity, wanting to partner on solutions that boost domestic production without ignoring market realities. Meanwhile, the administration is ramping up global pressure, launching trade probes against countries like Germany and negotiating pricing deals with the UK—all part of a broader strategy to reshape global drug pricing and prioritize American-made medicine.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
